Mark Tyndall

21.3k citations
263 papers · 16.3k · 2 hit papers · h-index 74

Impact in

  • Epidemiology top 0.05%
    • HIV, Drug Use, Sexual Risk
    • Substance Abuse Treatment and Outcomes
  • Hepatology top 0.2%
    • Hepatitis C virus research

Papers in

Mark Tyndall

257 papers receiving 15.6k citations

Mark Tyndall's Hit Papers

Opioid use disorder 2020 · 379 citations
3790+6+12Years since publication2505007501000

Peers

Mark Tyndall
Comparison fields: 5 of 154
  • Epidemiology 9.1k
  • Hepatology 1.9k
  • Infectious Diseases 3.8k
  • Virology 809
  • Toxicology 452
Replace Don C. Des Jarlais with:
Don C. Des Jarlais United States
Martin T. Schechter Canada
Peter Vickerman United Kingdom
Josiah D. Rich United States
Lisa Maher Australia
David D. Celentano United States
Tim Rhodes United Kingdom
Thomas Kerr Canada
Frederick L. Altice United States
Kimberly Page United States
Mark Tyndall relative to Don C. Des Jarlais United States Don C. Des Jarlais's profile →
Citations per field
00.5×1.5×
Don C. Des Jarlais · 1×
Citations per year

Countries citing papers authored by Mark Tyndall

Since Specialization
Citations

This map shows the geographic impact of Mark Tyndall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tyndall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tyndall more than expected).

Fields of papers citing papers by Mark Tyndall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Tyndall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tyndall. The network helps show where Mark Tyndall may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Tyndall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Tyndall Line = papers co-authored together Mark Tyndall links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 263 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
Hit paper breakdown →
20081023
2 2007405
3 2006394
4
Opioid use disorder
Hit paper breakdown →
2020379
5 2003342
6 2009269
7 2006258
8 2009251
9 2005237
10 2017228
11
Hospital utilization and costs in a cohort of injection drug users.
2001225
12 2008214
13 2011211
14
Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.
2003193
15
Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?
2001188
16
Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver.
2002184
17
Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
2001181
18 2006173
19 2004170
20 2007166

About Mark Tyndall

Mark Tyndall is a scholar working on Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health, Hepatology and Sociology and Political Science, having authored 263 papers that have together received 16.3k indexed citations. Recurring topics across this work include HIV, Drug Use, Sexual Risk (124 papers), HIV/AIDS Research and Interventions (61 papers), Opioid Use Disorder Treatment (43 papers), Hepatitis C virus research (42 papers), Sex work and related issues (29 papers), Hepatitis B Virus Studies (17 papers), HIV Research and Treatment (15 papers) and Reproductive tract infections research (14 papers). The work is most often cited by research in Epidemiology (9.1k citations), Hepatology (1.9k citations), Infectious Diseases (3.8k citations), Virology (809 citations) and Toxicology (452 citations). Mark Tyndall has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Evan Wood, Thomas Kerr, Julio Montaner, Robert S. Hogg, Kate Shannon, Martin T. Schechter, Kathy Li, Michael V. O’Shaughnessy, Steffanie A. Strathdee and Jean Shoveller. Their work appears in journals such as International Journal of Drug Policy, AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, Drug and Alcohol Dependence and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact